MIRM — Mirum Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Mirum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-52.6	-103	-84	-136	-163
Depreciation
Deferred Taxes
Non-Cash Items	5.93	13.3	-66.3	39.9	104
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	7.12	0.611	17	-21.1	-22.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities	-39.4	-89.1	-133	-120	-70.9
Capital Expenditures	-0.281	-0.225	-19	-0.278	-20.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-128	38.1	67.6	7.98	-87.1
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-128	37.9	48.5	7.7	-107
Financing Cash Flow Items	—	49.4	64.5	-5.55	-196
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	127	181	73.5	109	337
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-40	130	-10.7	-3.34	158